CurAegis Technologies, Inc. (OTCPK:CRGS) announced that it has entered into a securities purchase agreement with returning investor Geneva Roth Remark Holdings, Inc. for $35,000 on January 6, 2021. The company has issued convertible promissory note in the transaction. The notes have one-year term and bears interest at 8%, with any interest or principal not paid when due earning 22% interest. The notes are convertible into the common stock at a conversion price of 65% of the lowest per share closing price during the 20 days prior to conversion. The note may be prepaid in whole or in part from time to time by the company. The company will pay $3,500 to investor as legal fees and due diligence fee.